Pages that link to "Q44430840"

The following pages link to Combined effect of coenzyme Q10 and fenofibrate on forearm microcirculatory function in type 2 diabetes (Q44430840):

Displaying 34 items.

• Oxidized LDL and small LDL particle size are independently predictive of a selective defect in microcirculatory endothelial function in type 2 diabetes (Q28185611) (← links)
• Fenofibrate: a novel formulation (Triglide) in the treatment of lipid disorders: a review (Q28220294) (← links)
• Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease (Q28287250) (← links)
• PPARalpha: an emerging therapeutic target in diabetic microvascular damage. (Q30390555) (← links)
• Effect of coenzyme Q10 intake on endogenous coenzyme Q content, mitochondrial electron transport chain, antioxidative defenses, and life span of mice. (Q33711709) (← links)
• Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment (Q33776230) (← links)
• Coenzyme q10 therapy (Q33956936) (← links)
• Interactions of commonly used dietary supplements with cardiovascular drugs: a systematic review (Q34287966) (← links)
• Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials. (Q34685307) (← links)
• Therapeutic Effects of PPAR α on Neuronal Death and Microvascular Impairment (Q35078274) (← links)
• Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis. (Q35614877) (← links)
• Coenzyme Q10 and diabetic endotheliopathy: oxidative stress and the 'recoupling hypothesis'. (Q35837905) (← links)
• Mechanisms, significance and treatment of vascular dysfunction in type 2 diabetes mellitus: focus on lipid-regulating therapy. (Q35989396) (← links)
• Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: a randomized, double blind, placebo-controlled trial. (Q36093107) (← links)
• The effects of lipid-lowering drug therapy on cardiovascular responsiveness in type 2 diabetic patients (Q36347868) (← links)
• Hemodynamic effects of fenofibrate and coenzyme Q10 in type 2 diabetic subjects with left ventricular diastolic dysfunction (Q36807491) (← links)
• Coenzyme Q10: is there a clinical role and a case for measurement? (Q36869671) (← links)
• Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. (Q36892489) (← links)
• Endothelial function, arterial stiffness and lipid lowering drugs (Q36936335) (← links)
• Therapeutic use of coenzyme Q10 and coenzyme Q10-related compounds and formulations. (Q37724200) (← links)
• Iatrogenic hyperhomocysteinemia in patients with metabolic syndrome: A systematic review and metaanalysis (Q37789491) (← links)
• Coenzyme Q(10) , endothelial function, and cardiovascular disease. (Q37889812) (← links)
• Is there a place for coenzyme Q in the management of metabolic disorders associated with obesity? (Q38056543) (← links)
• Role of dietary and endogenous antioxidants in diabetes (Q38192085) (← links)
• Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies (Q38460480) (← links)
• Fenofibrate Treatment Enhances Antioxidant Status and Attenuates Endothelial Dysfunction in Streptozotocin-Induced Diabetic Rats (Q41605028) (← links)
• World Congress on the insulin resistance syndrome, 2009: cellular mechanisms of insulin resistance (Q42707587) (← links)
• Effects of coenzyme q10 supplementation on serum lipoproteins, plasma fibrinogen, and blood pressure in patients with hyperlipidemia and myocardial infarction (Q43148428) (← links)
• Fenofibrate improves endothelial function in the brachial artery and forearm resistance arterioles of statin-treated Type 2 diabetic patients (Q43202813) (← links)
• Microvascular endothelial function in subjects with Type 2 diabetes and the effect of lipid-lowering therapy. (Q46885814) (← links)
• The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials (Q50057739) (← links)
• Effects of fenofibrate therapy on plasma ubiquinol-10 and ubiquinone-10 levels in Japanese patients with hyperlipidemia and type 2 diabetes mellitus (Q51501343) (← links)
• Effectiveness of Coenzyme Q10 Supplementation for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis (Q57300294) (← links)
• Effects of coenzyme Q on cardiovascular and metabolic biomarkers in overweight and obese patients with type 2 diabetes mellitus: a pooled analysis (Q60048844) (← links)